UC Davis researchers won a $3.1M NIH R01 to test nanoparticles that form fiber networks at tumor sites to deliver drugs on demand in preclinical studies.
UC Davis' Shape-Shifting 'Tumor Glue' Targets Cancer In Sacramento Labs
UC Davis researchers won a $3.1M NIH R01 to test nanoparticles that form fiber networks at tumor sites to deliver drugs on demand in preclinical studies.